UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 14, 2014
SIGMA LABS, INC.
(Exact name of registrant as specified in its charter)
Nevada | 033-02783-S | 82-0404220 | ||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
3900 Paseo del Sol
Santa Fe, New Mexico 87507
_________________________
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (505) 438-2576
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On November 14, 2014, Sigma Labs, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the third quarter ended September 30, 2014 and an update on recent business developments. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information furnished under this Item 2.02, including the accompanying Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any subsequent filing by the Company under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as specifically stated in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number | Description | |
99.1 | Press Release of Sigma Labs, Inc., dated November 14, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 14, 2014 |
SIGMA LABS, INC.
By: /s/ Mark J. Cola Name: Mark J. Cola Title: President and Chief Executive Officer |
Exhibit 99.1
Sigma Labs Announces Third Quarter 2014 Financial Results
Launched PrintRite3D® INSPECT™; Begun Marketing of 3D Printed Parts
SANTA FE, N.M. – November 14, 2014 – Sigma Labs, Inc. (OTCQB: SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing and other advanced manufacturing technologies, today announced financial results for the three and nine months ended September 30, 2014 and provided a business update.
Recent Highlights
· | Sigma Labs commercially launched its PrintRite3D® INSPECT™ quality assurance software and began actively marketing this unique software application to potential customers. Initial revenue is expected as early as the fourth quarter of 2014. |
· | The Company also took delivery of its first EOS M290 3D metal printer, now being integrated with Sigma Labs’ PrintRite3D® quality assurance system for use in the production of precision metal parts. Sigma Labs is responding to requests for quotes and anticipates contract manufacturing orders over the next several months. |
· | Sigma Labs recently received a contract from Honeywell Aerospace as part of a Defense Advanced Research Project Agency (DARPA) Phase II award. The DARPA program’s goal is to develop an Integrated Computational Material Engineering (ICME) framework to accurately predict the properties of metal components produced using additive manufacturing. |
· | The Company was awarded an initial contract from Edison Welding Institute (EWI) as part of the previously-announced grant from the U.S. Department of Commerce's National Institute of Standards and Technology (NIST) for the development of in-process sensing and monitoring capabilities to ensure consistent quality in 3D printing. The contract will evaluate PrintRite3D® technology for monitoring and control applications. |
· | The Company continues its previously-announced work with Materialise NV of Belgium, GE, Adurant Technologies, and other organizations to test, advance, and strengthen Sigma Labs’ propriety IPQA® technology. |
“Sigma Labs has had a very busy second half of 2014, and our path to commercialization and profitability continues to bear fruit,” said Mark Cola, President and CEO. “Most notably, we officially launched our PrintRite3D® INSPECT™ quality assurance software and are currently demonstrating it to a number of potential customers eager to improve their 3D printing manufacturing. Our brand is clearly gaining traction in the marketplace through the many demonstration projects now underway, as well as our participation in various organizations including the Additive Manufacturing Consortium, part of the EWI. We won our first NIST contract with the EWI and were also awarded an order from Honeywell for a Phase II DARPA development project that should further validate our software and broaden the audience of potential customers.
“Both the EWI and Honeywell contracts will begin in the fourth quarter, and we expect to see initial product revenue from our INSPECT™ software this year as well. In addition, we recently took delivery of an EOS M290 machine and are already preparing for prototyping and small lot production of high-precision metal components. The Company will be able to offer contract manufacturing to a variety of industrial companies and further demonstrate our unique software applications to advance the speed, quality and consistency of 3D printing.
“We are on the right track to post significant top line growth next year tied to our product rollout strategy, which includes the expected launch of our PrintRite3D® DEFORM™ software early in 2015. The future looks bright, and we are certainly encouraged by what we see as growing demand for metal-based additive manufacturing applications going forward.”
2014 Third Quarter and Year-to-Date Financial Results
Service revenue for the three and nine months ended September 30, 2014 was approximately $0.1 million and $0.3 million, respectively, versus approximately $0.3 million and $0.8 million for the same periods in 2013. The revenue decline year-over-year primarily reflects lower consulting revenue as the Company invests in the transition from services to product sales.
The Company reported a net loss for the three and nine months ended September 30, 2014 of approximately $0.5 million and $2.8 million, respectively, or $(0.00) per diluted share, versus a loss of approximately $0.2 million and $0.5 million, respectively, or $(0.00) per diluted share, for the same periods in 2013. The higher loss reflects lower revenue and increased general and administrative expense, payroll expense, non-cash compensation expense and warrant expense.
Investor Webcast
The Company will host an investor webcast, primarily to review the third quarter results and recent developments, on December 4, 2014 at 10:45 a.m. Eastern Time. Additional information about this event will be provided ahead of time.
About Sigma Labs, Inc.
Sigma Labs, Inc., through its wholly-owned subsidiary B6 Sigma, Inc., develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies. For more information please visit us at www.sigmalabsinc.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Sigma Labs, Inc.
Investor Relations Contact:
Chris Witty
cwitty@darrowir.com
646-438-9385
Sigma Labs, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of Operations
Three Months and Nine Months Ended September 30, 2014 and 2013
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||
INCOME | ||||||||||||||||
Services | $ | 92,449 | $ | 280,831 | $ | 322,091 | $ | 753,080 | ||||||||
Total Revenue | 92,449 | 280,831 | 322,091 | 753,080 | ||||||||||||
COST OF SERVICE REVENUE | 36,326 | 159,367 | 176,954 | 395,846 | ||||||||||||
GROSS PROFIT | 56,123 | 121,464 | 145,137 | 357,234 | ||||||||||||
EXPENSES | ||||||||||||||||
General & Administration | 296,085 | 181,562 | 712,264 | 463,911 | ||||||||||||
Payroll Expense | 84,865 | 29,137 | 387,564 | 184,963 | ||||||||||||
Non-cash Stock Compensation | 215,550 | 96,500 | 566,950 | 213,200 | ||||||||||||
Warrant Expense | - | - | 1,283,333 | - | ||||||||||||
Total Expenses | 596,500 | 307,199 | 2,950,111 | 862,074 | ||||||||||||
OTHER INCOME (EXPENSE) | ||||||||||||||||
Interest Income | 939 | 308 | 2,721 | 319 | ||||||||||||
Total Other Income (Expense) | 939 | 308 | 2,721 | 319 | ||||||||||||
INCOME (LOSS) BEFORE INCOME TAXES | (539,438 | ) | (185,427 | ) | (2,802,253 | ) | (504,521 | ) | ||||||||
Current Income Tax Expense | - | - | - | - | ||||||||||||
Deferred Income Tax Expense | - | - | - | - | ||||||||||||
Net Income (Loss) | $ | (539,438 | ) | $ | (185,427 | ) | $ | (2,802,253 | ) | $ | (504,521 | ) | ||||
Loss per Common Share - Basic and Diluted | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||
Weighted Average Number of Shares | ||||||||||||||||
Outstanding - Basic and Diluted | 616,610,626 | 533,549,034 | 607,463,863 | 466,440,698 |
Sigma Labs, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
September 30, 2014 and December 31, 2013
September 30, 2014 | December 31, 2013 | |||||||
(Unaudited) | (Audited) | |||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash | $ | 3,682,533 | $ | 992,448 | ||||
Accounts Receivable, net | 48,007 | 303,445 | ||||||
Inventory | 49,264 | 1,167 | ||||||
Prepaid Assets | 17,791 | 25,074 | ||||||
Total Current Assets | 3,797,595 | 1,322,134 | ||||||
Other Assets | ||||||||
Furniture and Equipment, net | 25,201 | 11,419 | ||||||
Equipment Deposit | 241,333 | - | ||||||
Deferred Stock Offering Costs | 108,380 | 17,426 | ||||||
Intangible Assets, net | 74,750 | 70,494 | ||||||
Total Other Assets | 449,664 | 99,339 | ||||||
TOTAL ASSETS | $ | 4,247,259 | $ | 1,421,473 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | ||||||||
Accounts Payable | $ | 96,800 | $ | 102,625 | ||||
Accrued Expenses | 46,241 | 38,536 | ||||||
Total Current Liabilities | 143,041 | 141,161 | ||||||
TOTAL LIABILITIES | 143,041 | 141,161 | ||||||
Stockholders' Equity | ||||||||
Preferred Stock, $0.001 par; 10,000,000 shares authorized; | ||||||||
None issued and outstanding | - | - | ||||||
Common Stock, $0.001 par; 750,000,000 shares authorized; | ||||||||
618,241,061 issued and 612,641,061 | ||||||||
outstanding at September 30, 2014 and | ||||||||
559,766,061 issued and 556,816,061 | ||||||||
outstanding at December 31, 2013 | 618,241 | 559,766 | ||||||
Additional Paid-In Capital | 9,658,788 | 3,561,204 | ||||||
Less Deferred Compensation | ||||||||
5,600,000 and 2,950,000 common shares, respectively | (618,800 | ) | (88,900 | ) | ||||
Retained Earnings (Deficit) | (5,554,011 | ) | (2,751,758 | ) | ||||
Total Stockholders' Equity | 4,104,218 | 1,280,312 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 4,247,259 | $ | 1,421,473 |